BIO-key receives Nasdaq delisting notice for late 10-Q; restating prior periods

BIO KEY INTERNATIONAL INC

Received Nasdaq notice on May 22, 2024 for non-compliance with Listing Rule 5250(c)(1) due to late 10-Q filing for quarter ended March 31, 2024.
Company remains delinquent on 2023 10-K; restating 2023 quarterly financial statements (Q1, Q2, Q3 2023).
Must submit compliance plan by June 17, 2024; potential extension to October 14, 2024 if plan accepted.
No immediate effect on listing or trading of common stock on Nasdaq Capital Market.
Company intends to file Form 10-Q and Form 10-K as soon as practicable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.